Synthesis of bisphosphonate derivatives of ATP by T4 DNA ligase, ubiquitin activating enzyme (E1) and other ligases

Biochemical Pharmacology

Volumn 75, Issue 10, 2008, Pages 1959-1965

  Günther Sillero, María A ^a   de Diego, Anabel ^a   Pérez Zúñiga, Francisco J ^a   Sillero, Antonio ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Bisphosphonates; Dinucleoside polyphosphates; Ligases; Osteoporosis; T4 DNA ligase; Ubiquitin activating enzyme (E1)

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID; GUANOSINE TRIPHOSPHATE; LIGASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MEDRONIC ACID; PAMIDRONIC ACID; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TRIPOLYPHOSPHATE; UBIQUITIN PROTEIN LIGASE;

ARTICLE; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME SUBSTRATE; OSTEOPOROSIS; PRIORITY JOURNAL;

ACETATE-COA LIGASE; ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; DIPHOSPHONATES; DNA LIGASES; LUCIFERASES; UBIQUITIN-ACTIVATING ENZYMES;

EID: 42649092514     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.02.017     Document Type: Article

References (29)

1. Günther Sillero M.A., de Diego A., Silles E., Pérez-Zúñiga F., and Sillero A. Synthesis of bisphosphonate derivatives of ATP by T4 RNA ligase. FEBS Lett 580 (2006) 5723-5727
2. Fleisch H. Diphosphonates: history and mechanisms of action. Metab Bone Dis Relat Res 3 (1981) 279-287
3. Fleisch H. Development of bisphosphonates. Breast Cancer Res 4 (2002) 30-34
4. Reszka A.A., and Rodan G.A. Bisphosphonate mechanism of action. Curr Rheumatol Rep 5 (2003) 65-74
5. Epstein S., and Zaidi M. Biological properties and mechanism of action of ibandronate: application to the treatment of osteoporosis. Bone 37 (2005) 433-440
6. Bergstrom J.D., Bostedor R.G., Masarachia P.J., Reszka A.A., and Rodan G. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 373 (2000) 231-241
7. Rogers M.J. New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 9 (2003) 2643-2658
8. Zamecnik P.C., Stephenson M.L., Janeway C.M., and Randerath K. Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase. Biochem Biophys Res Commun 24 (1966) 91-97
9. 3-methylenetetraphosphate). Biochemistry 27 (1988) 1897-1901
10. Rogers M.J., Ji X., Russell R.G., Blackburn G.M., Williamson M.P., Bayless A.V., et al. Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum. Biochem J 303 Pt 1 (1994) 303-311
11. Rogers M.J., Brown R.J., Hodkin V., Blackburn G.M., Russell R.G., and Watts D.J. Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes. Biochem Biophys Res Commun 224 (1996) 863-869
12. Auriola S., Frith J., Rogers M.J., Koivuniemi A., and Mönkkönen J. Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry. J Chromatogr 704 (1997) 187-195
13. Frith J.C., Mönkkönen J., Blackburn G.M., Russell R.G., and Rogers M.J. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5′-(β,γ-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 12 (1997) 1358-1367
14. Lehenkari P.P., Kellinsalmi M., Napankangas J.P., Ylitalo K.V., Mönkkönen J., Rogers M.J., et al. Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite. Mol Pharmacol 61 (2002) 1255-1262
15. Amin D., Cornell S.A., Gustafson S.K., Needle S.J., Ullrich J.W., Bilder G.E., et al. Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. J Lipid Res 33 (1992) 1657-1663
16. Fisher J.E., Rogers M.J., Halasy J.M., Luckman S.P., Hughes D.E., Masarachia P.J., et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci USA 96 (1999) 133-138
17. Benford H.L., Frith J.C., Auriola S., Mönkkönen J., and Rogers M.J. Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol 56 (1999) 131-140
18. Mönkkönen H., Auriola S., Lehenkari P., Kellinsalmi M., Hassinen I.E., Vepsalainen J., et al. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. Br J Pharmacol 147 (2006) 437-445
19. Sillero A., and Günther Sillero M.A. Synthesis of dinucleoside polyphosphates catalyzed by firefly luciferase and several ligases. Pharmacol Ther 87 (2000) 91-102
20. Madrid O., Martin D., Atencia E.A., Sillero A., and Günther Sillero M.A. T4 DNA ligase synthesizes dinucleoside polyphosphates. FEBS Lett 433 (1998) 283-286
21. Günther Sillero M.A., de Diego A., Silles E., and Sillero A. Synthesis of (di)nucleoside polyphosphates by the ubiquitin activating enzyme E1. FEBS Lett 579 (2005) 6223-6229
22. Ortiz B., Sillero A., and Günther Sillero M.A. Specific synthesis of adenosine(5′)tetraphospho(5′)nucleoside and adenosine(5′)oligophospho(5′)adenosine (n > 4) catalyzed by firefly luciferase. Eur J Biochem 212 (1993) 263-270
23. Fontes R., Günther Sillero M.A., and Sillero A. Acyl coenzyme A synthetase from Pseudomonas fragi catalyzes the synthesis of adenosine 5′-polyphosphates and dinucleoside polyphosphates. J Bacteriol 180 (1998) 3152-3158
24. Guranowski A., Günther Sillero M.A., and Sillero A. Adenosine 5′-tetraphosphate and adenosine 5′-pentaphosphate are synthesized by yeast acetyl coenzyme A synthetase. J Bacteriol 176 (1994) 2986-2990
25. Lindahl T., and Barnes D.E. Mammalian DNA ligases. Annu Rev Biochem 61 (1992) 251-281
26. Hershko A., and Ciechanover A. The ubiquitin system. Annu Rev Biochem 67 (1998) 425-479
27. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82 (2002) 373-428
28. Bartl R., Frisch B., von Tresckow E., and Bartl C. Bisphosphonates in medical practice (2007), Springer-Verlag, Berlin
29. Moreau M.F., Guillet C., Massin P., Chevalier S., Gascan H., Basle M.F., et al. Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol 73 (2007) 718-723